EXO-TARGET

Live / Registered — Registered (as of 07 Jan 2025)

What this means for you

Registered since 07 Jan 2025. The owner can stop confusingly similar uses in the classes it covers.

Record

Serial number
90357299
Registration number
7637167
Mark type
Stylized text
Filed
03 Dec 2020
Published for opposition
19 Nov 2024
Registered
07 Jan 2025
Attorney of record
Janice Housey

Goods and services

  • Class 001 — Chemicals: Biological preparations, other than for medical or veterinary purposes; biological tissue cultures, other than for medical or veterinary purposes; biological preparation for use in cell cultures other than for medical or veterinary use; biological preparation for use in the manufacture of pharmaceuticals; chemical additives for use in the manufacture of pharmaceuticals; chemical additives for use in the manufacture of cosmetics; protein for use in the manufacture of cosmetics; proteins for the food industry; chemical reagents, other than for medical or veterinary purpose
  • Class 005 — Pharmaceuticals: Pharmaceutical preparations for treating cancer, metabolic disease, inflammatory disease, genetic disease, infectious diseases, cardiovascular disease, respiratory disease, neurological disease, auto-immune disease, fibrosis disease; chemico-pharmaceutical preparations for the treatment of cancer, metabolic disease, inflammatory disease, genetic disease, infectious diseases, cardiovascular disease, respiratory disease, neurological disease, auto-immune disease, fibrosis disease; drug delivery agents in the form of capsules, tablets, pills, powders, liquids, suspensions, injection, creams, emulsions, gels, liniments, lotions, ointments, pathes, solutions, syrups, aerosols, granules, implants, inhalants, pellets that facilitate the delivery of pharmaceutical preparations for the treatment of cancer, metabolic disease, inflammatory disease, genetic disease, infectious diseases, cardiovascular disease, respiratory disease, neurological disease, auto-immune disease, fibrosis disease; biological preparations in the nature of comprising extracellular vesicles known as exosomes for therapeutic applications; extracellular vesicles for pharmaceutical purposes for the treatment of cancer, metabolic disease, inflammatory disease, genetic disease, infectious diseases, cardiovascular disease, respiratory disease, neurological disease, auto-immune disease, fibrosis disease; biochemical drug delivery agent in the form of capsules, tablets, pills, powders, liquids, suspensions, injection, creams, emulsions, gels, liniments, lotions, ointments, pathes, solutions, syrups, aerosols, granules, implants, inhalants, pellets that facilitate the delivery of pharmaceutical preparations for the treatment of cancer, metabolic disease, inflammatory disease, genetic disease, infectious diseases, cardiovascular disease, respiratory disease, neurological disease, auto-immune disease, fibrosis disease; nutraceutical preparations for therapeutic or medical purposes for the treatment of cancer, metabolic disease, inflammatory disease, genetic disease, infectious diseases, cardiovascular disease, respiratory disease, neurological disease, auto-immune disease, fibrosis disease; chemical preparations for pharmaceutical purposes for the treatment of cancer, metabolic disease, inflammatory disease, genetic disease, infectious diseases, cardiovascular disease, respiratory disease, neurological disease, auto-immune disease, fibrosis disease; chemical preparations for medical purposes for the treatment of cancer, metabolic disease, inflammatory disease, genetic disease, infectious diseases, cardiovascular disease, respiratory disease, neurological disease, auto-immune disease, fibrosis disease; preparations of microorganisms for medical and veterinary use for the treatment of cancer, metabolic disease, inflammatory disease, genetic disease, infectious diseases, cardiovascular disease, respiratory disease, neurological disease, auto-immune disease, fibrosis disease; reagents for use in medical genetic testing; diagnostic reagents for medical use; biological preparations for medical or veterinary purposes for the treatment of cancer, metabolic disease, inflammatory disease, genetic disease, infectious diseases, cardiovascular disease, respiratory disease, neurological disease, auto-immune disease, fibrosis disease; biological reagents for clinical medical use
  • Class 042 — Scientific and technological services: Biotechnology research; technological research in the field of cell biology; laboratory research in the field of cell biology; pharmaceutical drug development services; genetic testing for scientific research purposes; research in the field of chemistry; drug discovery services; medical research and development services; pharmaceutical research and development services; biopharmaceutical research and development services

Owner

Prosecution history

  • 16 Mar 2026 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
  • 16 Mar 2026 — TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
  • 16 Mar 2026 — TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
  • 16 Mar 2026 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
  • 16 Mar 2026 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
  • 16 Mar 2026 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
  • 16 Mar 2026 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
  • 07 Jan 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
  • 07 Jan 2025 — REGISTERED-PRINCIPAL REGISTER
  • 19 Nov 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
  • 19 Nov 2024 — PUBLISHED FOR OPPOSITION
  • 13 Nov 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
  • 11 Oct 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
  • 07 Oct 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED
  • 07 Oct 2024 — CORRESPONDENCE RECEIVED IN LAW OFFICE

View this trademark record on Marksy